Literature DB >> 10918103

Combined evidence-based literature analysis and consensus guidelines for stocking of emergency antidotes in the United States.

R C Dart1, L R Goldfrank, P A Chyka, D Lotzer, A D Woolf, J McNally, W R Snodgrass, K R Olson, E Scharman, R J Geller, D Spyker, M Kraft, R Lipsy.   

Abstract

STUDY
OBJECTIVE: To develop guidelines for the stocking of antidotes at hospitals that accept emergency admissions using combined evidence-based and consensus methods.
METHODS: Study participants were 12 medical care providers from disciplines that are affected by insufficient stocking of emergency antidotes (clinical pharmacology, critical care, clinical pharmacy, emergency medicine, hospital pharmacy, internal medicine, managed care pharmacy, clinical toxicology, pediatrics, poison control centers, pulmonary medicine, regulatory medicine). Selection of individuals for the study panel was based on evidence of previous antidote research or perspective regarding the purchase and use of antidotes. The literature regarding each antidote was systematically amassed using pre-1966 literature files, current MEDLINE searches, the reference lists of major medical textbooks, and citations solicited from the consensus panel. Articles relevant to 4 defined core questions were included. These articles formed the basis of an evidence-based analysis performed by the principal investigator. After literature analysis, a literature summary and proposed guidelines for antidote stocking were submitted to the panel. Consensus was formed by electronic iterative presentation of alternatives to each panel member using a modified Delphi method. All panel members participated in 5 rounds of guideline analysis of 20 antidotes.
RESULTS: Of the 20 antidotes, 16 antidotes were ultimately recommended for stocking (N -acetylcysteine, atropine, Crotalid snake antivenin, calcium gluconate and chloride, cyanide antidote kit, deferoxamine, digoxin immune Fab, dimercaprol, ethanol, fomepizole, glucagon, methylene blue, naloxone, pralidoxime, physostigmine, sodium bicarbonate), 2 were not recommended for stocking (black widow antivenin, ethylenediamine tetraacetic acid), and consensus could not be reached for 2 antidotes (flumazenil, physostigmine).
CONCLUSION: These guidelines provide a tool to be used in revising or creating policies and procedures with regard to the stocking of antidotes in hospitals that accept emergency patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918103     DOI: 10.1067/mem.2000.108182

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  10 in total

1.  ACMT Position Statement: Addressing the Rising Cost of Prescription Antidotes.

Authors:  Maryann Mazer-Amirshahi; Andrew Stolbach; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2017-11-28

2.  Correction to: ACMT Position Statement: Addressing the Rising Cost of Prescription Antidotes.

Authors:  Maryann Mazer-Amirshahi; Andrew Stolbach; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2018-06

3.  Availability of antidotes at acute care hospitals in Ontario.

Authors:  D N Juurlink; M A McGuigan; T W Paton; D A Redelmeier
Journal:  CMAJ       Date:  2001-07-10       Impact factor: 8.262

4.  Expert consensus for a national essential antidote list: E-Delphi method.

Authors:  Dalal Al-Taweel; Samuel Koshy; Sara Al-Ansari; Asmaa Al-Haqan; Bedoor Qabazard
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

5.  Tiapride pre-treatment in acute exposure to paraoxon: comparison of effects of administration at different points-in-time in rats.

Authors:  G A Petroianu; M Y Hasan; S M Nurulain; K Arafat; M Shafiullah; R Sheen
Journal:  Mol Cell Biochem       Date:  2006-02-15       Impact factor: 3.396

Review 6.  Pharmacological management of anticholinergic delirium - theory, evidence and practice.

Authors:  Andrew H Dawson; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2015-12-29       Impact factor: 4.335

7.  Kind and estimated stocking amount of antidotes for initial treatment for acute poisoning at emergency medical centers in Korea.

Authors:  Chang Hwan Sohn; Seung Mok Ryoo; Kyoung Soo Lim; Won Kim; Hoon Lim; Bum Jin Oh
Journal:  J Korean Med Sci       Date:  2014-11-04       Impact factor: 2.153

8.  Insufficient stocking of cyanide antidotes in US hospitals that provide emergency care.

Authors:  Lucas Gasco; Margaret B Rosbolt; Vikhyat S Bebarta
Journal:  J Pharmacol Pharmacother       Date:  2013-04

9.  Availability of treatment resources for the management of acute toxic exposures and poisonings in emergency departments among various types of hospitals in Palestine: a cross-sectional study.

Authors:  Sa'ed H Zyoud; Samah W Al-Jabi; Yara I Bali; Afnan M Al-Sayed; Waleed M Sweileh; Rahmat Awang
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2014-02-21       Impact factor: 2.953

10.  Evaluation of upper extremity neurorehabilitation using technology: a European Delphi consensus study within the EU COST Action Network on Robotics for Neurorehabilitation.

Authors:  Ann-Marie Hughes; Sofia Barbosa Bouças; Jane H Burridge; Margit Alt Murphy; Jaap Buurke; Peter Feys; Verena Klamroth-Marganska; Ilse Lamers; Gerdienke Prange-Lasonder; Annick Timmermans; Thierry Keller
Journal:  J Neuroeng Rehabil       Date:  2016-09-23       Impact factor: 4.262

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.